Bausch & Lomb Americas Inc.
15 drugs in NADAC|15 Generic,0 Brand
Bausch & Lomb Americas Inc. lists 15 NDCs in the CMS NADAC file (15 generic, 0 brand), at an average NADAC of $13.01 per unit, with a week-over-week move of +0.5% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
15
15G / 0B
Avg Price / Unit
$13.0115
$1.05 – $30.72
Avg 7d Change
+0.45%
Across 15 drugs with changes
7d Activity
of 15 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Timolol Maleate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
beta-Adrenergic Blocker therapeutic class
Review the broader class where Bausch & Lomb Americas Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Bausch & Lomb Americas Inc. make?
Bausch & Lomb Americas Inc. lists 15 NDCs in the CMS NADAC file — 15 generic and 0 brand products.
What is the average price of Bausch & Lomb Americas Inc. drugs?
The average NADAC across Bausch & Lomb Americas Inc.'s portfolio is $13.0115 per unit, ranging from $1.0460 to $30.7171.
What types of drugs does Bausch & Lomb Americas Inc. make?
Bausch & Lomb Americas Inc. makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are beta-Adrenergic Blocker (6), Corticosteroid (5), Histamine-1 Receptor Antagonist (2), Nonsteroidal Anti-inflammatory Drug (1), Ester Local Anesthetic (1).
Has Bausch & Lomb Americas Inc. had any drug recalls?
No FDA enforcement recalls are matched to Bausch & Lomb Americas Inc. in the openFDA feed.
How has Bausch & Lomb Americas Inc.'s pricing changed recently?
Over the past 7 days, 5 Bausch & Lomb Americas Inc. products rose and 10 fell, with a portfolio-wide average change of +0.5%.